In Vitro and In Vivo Antibacterial Activities of a Novel Glycylcycline, the 9-t-Butylglycylamido Derivative of Minocycline (GAR-936)

Gelijkaardige items

• Comparison of the In Vitro Activity of the Glycylcycline Tigecycline (Formerly GAR-936) with Those of Tetracycline, Minocycline, and Doxycycline against Isolates of Nontuberculous Mycobacteria
  door: Wallace, Jr., Richard J., et al.
  Gepubliceerd in: (2002)
• In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines.
  door: Testa, R T, et al.
  Gepubliceerd in: (1993)
• In Vitro Activities of the Glycylcycline GAR-936 against Gram-Positive Bacteria
  door: Boucher, Helen W., et al.
  Gepubliceerd in: (2000)
• Therapeutic Efficacy of GAR-936, a Novel Glycylcycline, in a Rat Model of Experimental Endocarditis
  door: Murphy, Timothy M., et al.
  Gepubliceerd in: (2000)
• Activities of the Glycylcycline Tigecycline (GAR-936) against 1,924 Recent European Clinical Bacterial Isolates
  door: Milatovic, D., et al.
  Gepubliceerd in: (2003)